Application 021503
- Type
- NDA
- Sponsor
- AGOURON PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIRACEPT | NELFINAVIR MESYLATE | TABLET;ORAL | EQ 625MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021503-001 | VIRACEPT | NELFINAVIR MESYLATE | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021503-001 | VIRACEPT | EQ 625MG BASE | TABLET / ORAL | RLD, RS | 2003-04-30 | f41ea6bd6efb… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VIRACEPT | NELFINAVIR MESYLATE | AGOURON | e72c2bc6-9462-4a2e-8e1d-b97592376cbd | 2025-12-11 | Warnings, Adverse reactions | 021503 NDA021503 63010-027 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 53808-0809 | Viracept | NELFINAVIR MESYLATE | State of Florida DOH Central Pharmacy | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
| 63010-027 | VIRACEPT | nelfinavir mesylate | AGOURON | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66880 | SUPPL | 2021-03-25 |
| 66874 | SUPPL | 2021-03-25 |
| 45359 | SUPPL | 2016-09-22 |
| 45302 | SUPPL | 2016-09-20 |
| 15622 | SUPPL | 2015-04-07 |
| 27949 | SUPPL | 2015-03-31 |
| 15621 | SUPPL | 2013-06-04 |
| 27948 | SUPPL | 2013-05-31 |
| 27947 | SUPPL | 2012-04-11 |
| 37084 | SUPPL | 2012-04-09 |
| 5564 | SUPPL | 2012-02-27 |
| 15620 | SUPPL | 2012-02-24 |
| 15619 | SUPPL | 2011-03-04 |
| 27946 | SUPPL | 2011-02-28 |
| 37083 | SUPPL | 2010-05-03 |
| 15618 | SUPPL | 2010-05-03 |
| 27945 | SUPPL | 2010-04-28 |
| 5563 | SUPPL | 2010-04-28 |
| 5562 | SUPPL | 2008-11-26 |
| 27944 | SUPPL | 2008-02-14 |
| 15617 | SUPPL | 2008-02-14 |
| 21702 | SUPPL | 2007-08-06 |
| 21701 | SUPPL | 2007-08-06 |
| 15616 | SUPPL | 2007-08-02 |
| 27943 | SUPPL | 2007-01-08 |
| 37082 | SUPPL | 2006-12-28 |
| 21700 | ORIG | 2005-12-16 |
| 5561 | SUPPL | 2005-10-20 |
| 15615 | SUPPL | 2005-09-30 |
| 15614 | SUPPL | 2004-06-07 |
| 5560 | SUPPL | 2004-06-07 |
| 15612 | SUPPL | 2004-04-05 |
| 27941 | SUPPL | 2004-03-24 |
| 27942 | SUPPL | 2003-08-29 |
| 15613 | SUPPL | 2003-08-28 |
| 5559 | ORIG | 2003-05-29 |
| 15611 | ORIG | 2003-05-06 |